Anbio Biotechnology NNNN
NASDAQ NNNN
$3.60 -0.13 (-3.49%)
As of: Oct 21, 2026 · 2:11 PM EDT

Anbio Biotechnology (NNNN) Payables (2023 - 2025)

Updated

Anbio Biotechnology (NNNN) recorded Payables of $60,350 in the quarter ended Jun 30, 2025.

Analysis

Anbio Biotechnology (NNNN) Payables (2023 - 2025) Analysis & Trends

As of Dec 31, 2024, Anbio Biotechnology reported Payables of $1.63 million, up 96.5% from the prior year.

  • Across earlier years, Payables came in at $827,151 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Thermo Fisher Scientific 257.50 Bn 236.53 Bn 4.88 Bn 3.27 Bn
2 Abbott Laboratories 171.95 Bn 142.38 Bn 7.27 Bn 5.89 Bn
3 Danaher 162.71 Bn 146.52 Bn 3.61 Bn 1.82 Bn
4 Intuitive Surgical 152.49 Bn 131.91 Bn 1.96 Bn 277.20 Mn
5 Medtronic 119.67 Bn 84.92 Bn 6.34 Bn 2.70 Bn
6 Stryker 114.10 Bn 100.22 Bn 4.50 Bn 2.00 Bn
7 Boston Scientific 65.67 Bn 60.43 Bn 3.85 Bn 1.23 Bn
8 Becton Dickinson 53.59 Bn 50.74 Bn 2.32 Bn 6.11 Bn
9 Edwards Lifesciences 50.97 Bn 34.98 Bn 1.35 Bn 210.50 Mn
10 Anbio Biotechnology 157.22 Mn 110.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 60,350.00
Dec 31, 2024 1.63 Mn
Dec 31, 2023 827,151.00
API Access

Anbio Biotechnology Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=NNNN&period=max&api_key=YOUR_API_KEY